688062.SH
Mabwell (Shanghai) Bioscience Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 21.80
+1.68%Next report
Analyst consensus
- Next report date
- Apr 7, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 30, 2026
- EPS actual
- -CNY 0.65
- EPS estimate
- —
- Revenue actual
- CNY 185.0M
- Revenue estimate
- CNY 185.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 30, 2026 | — | -CNY 0.65 | — | CNY 185.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 7, 2027